In developed countries, hematological malignancies (HM) account for 8 to 10% of cancers
diagnosed annually and one-third of patients with HM (HMP) are expected to die from their …

The transformation of chronic lymphocytic leukemia (CLL) to high-grade B-cell lymphoma is
known as Richter syndrome (RS), a rare event with dismal prognosis. In this study, we …

The COVID‑19 pandemic has complicated current healthcare services for cancer patients.
Patients with haematological malignancies specifically seem vulnerable to SARS‑CoV‑2 …

This national Israeli multicenter retrospective study aimed to characterize the clinical course
of COVID-19 infection among patients with hematological malignancies, with special …

Background Little is known about patients with cancer presenting with acute chest
discomfort to the emergency department (ED). Objectives The aim of this study was to …

Objectives A retrospective population‐based study to determine the incidence and
prevalence of patients with the rare blood disease paroxysmal nocturnal haemoglobinuria …

For patients with blood cancers, comorbid mental health disorders at diagnosis likely affect
the entire disease trajectory, as they can interfere with disease information processing, lead …

Disseminated disease following invasive pulmonary aspergillosis (IPA) remains a significant
contributor to mortality amongst patients with hematologic malignancies (HMs). At the …

Background Transformation of chronic lymphocytic leukaemia (CLL) to diffuse large B-cell
lymphoma (DLCBL) type Richter's syndrome (RS) carries a dismal prognosis. Standard-of …

Histocompatibility testing is essential for donor identification and risk assessment in solid
organ and hematopoietic stem cell transplant. Additionally, it is useful for identifying donor …